Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities
about
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.Sleeping giants: emerging roles for the fat cadherins in health and disease.Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.Characterization of species-specific genes regulated by E2-2 in human plasmacytoid dendritic cellsDetection of DNA copy number alterations in cancer by array comparative genomic hybridization.Effective Treatment of a Childhood Blastic Plasmacytoid Dendritic Cell Neoplasm with a Cutaneous Tumor Alone by Stem Cell Transplantation with Reduced Intensity ConditioningBlastic plasmacytoid dendritic cell neoplasm: a single-center experience.Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature.Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.Neoplasms derived from plasmacytoid dendritic cells.Distal trisomy of 10q with distal monosomy of 15q due to a paternal translocation.A Case of Blastic Plasmacytoid Dendritic Cell Neoplasm Extensively Studied by Flow Cytometry and Immunohistochemistry.CLTC-ALK fusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm.
P2860
Q30249813-6FAF2632-7A90-45A5-BA35-1D0534572290Q34347563-E59DCE06-0E4E-4E10-B9C0-D3E62DA6AB58Q34955908-1E9EB1BE-B77E-4CBA-AD46-DD3411F9F9B2Q35860245-04B40C6B-A400-40E8-B457-0C6162CEA881Q36943634-E6C10B6D-FDEC-4E8B-A333-269B04F90718Q37048399-C1069241-CE34-4E7D-A064-520CB4434A41Q38058425-2E947D00-423D-4CE3-BCF9-6351133017EEQ38115993-DC6D11F6-27DD-49D4-8198-94CB5535DBB2Q38259612-DF44747F-26C9-4768-AAA7-5DFF48760411Q38689894-721772A6-06F2-449D-A730-23CD754B3503Q41937559-D112783D-100D-4792-8328-CCA437324CF8Q42266408-031D02C2-F957-4E90-8C57-48FB05D3B578Q46465423-B4CF5432-535C-4854-B11D-2C55032E09DB
P2860
Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities
description
article
@en
im Februar 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2007
@uk
name
Gene-expression profiling and ...... a as distinct disease entities
@en
Gene-expression profiling and ...... a as distinct disease entities
@nl
type
label
Gene-expression profiling and ...... a as distinct disease entities
@en
Gene-expression profiling and ...... a as distinct disease entities
@nl
prefLabel
Gene-expression profiling and ...... a as distinct disease entities
@en
Gene-expression profiling and ...... a as distinct disease entities
@nl
P2093
P1433
P1476
Gene-expression profiling and ...... a as distinct disease entities
@en
P2093
Cornelis P Tensen
Maarten H Vermeer
Rein Willemze
Remco Dijkman
Remco van Doorn
P304
P356
10.1182/BLOOD-2006-04-018143
P407
P577
2006-10-26T00:00:00Z